Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Receivables (2019 - 2024)

Historic Receivables for Cresco Labs (CRLBF) over the last 4 years, with Q4 2024 value amounting to $59.9 million.

  • Cresco Labs' Receivables rose 141.78% to $59.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $59.9 million, marking a year-over-year increase of 141.78%. This contributed to the annual value of $59.9 million for FY2024, which is 141.78% up from last year.
  • Cresco Labs' Receivables amounted to $59.9 million in Q4 2024, which was up 141.78% from $54.6 million recorded in Q3 2024.
  • In the past 5 years, Cresco Labs' Receivables ranged from a high of $59.9 million in Q4 2024 and a low of $49.7 million during Q1 2022
  • In the last 3 years, Cresco Labs' Receivables had a median value of $54.4 million in 2024 and averaged $54.5 million.
  • Over the last 5 years, Cresco Labs' Receivables had its largest YoY gain of 141.78% in 2024, and its largest YoY loss of 141.78% in 2024.
  • Cresco Labs' Receivables (Quarter) stood at $49.7 million in 2022, then increased by 18.8% to $59.0 million in 2023, then grew by 1.42% to $59.9 million in 2024.
  • Its Receivables stands at $59.9 million for Q4 2024, versus $54.6 million for Q3 2024 and $54.2 million for Q2 2024.